Correlation Between Viking Therapeutics and Tevogen Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Tevogen Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Tevogen Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Tevogen Bio Holdings, you can compare the effects of market volatilities on Viking Therapeutics and Tevogen Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Tevogen Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Tevogen Bio.

Diversification Opportunities for Viking Therapeutics and Tevogen Bio

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between Viking and Tevogen is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Tevogen Bio Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tevogen Bio Holdings and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Tevogen Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tevogen Bio Holdings has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Tevogen Bio go up and down completely randomly.

Pair Corralation between Viking Therapeutics and Tevogen Bio

Given the investment horizon of 90 days Viking Therapeutics is expected to generate 0.37 times more return on investment than Tevogen Bio. However, Viking Therapeutics is 2.68 times less risky than Tevogen Bio. It trades about -0.25 of its potential returns per unit of risk. Tevogen Bio Holdings is currently generating about -0.15 per unit of risk. If you would invest  7,175  in Viking Therapeutics on August 31, 2024 and sell it today you would lose (1,724) from holding Viking Therapeutics or give up 24.03% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viking Therapeutics  vs.  Tevogen Bio Holdings

 Performance 
       Timeline  
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Viking Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
Tevogen Bio Holdings 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Tevogen Bio Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tevogen Bio showed solid returns over the last few months and may actually be approaching a breakup point.

Viking Therapeutics and Tevogen Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viking Therapeutics and Tevogen Bio

The main advantage of trading using opposite Viking Therapeutics and Tevogen Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Tevogen Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tevogen Bio will offset losses from the drop in Tevogen Bio's long position.
The idea behind Viking Therapeutics and Tevogen Bio Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios